AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.39) by 35.9 percent. This is a 27.4 percent increase over losses of $(0.73) per share from the same period last year. The company reported quarterly sales of $18.51 million which missed the analyst consensus estimate of $21.14 million by 12.43 percent. This is a 66.73 percent increase over sales of $11.10 million the same period last year.